Literature DB >> 9585502

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway.

Z Dai1, R C Quackenbush, K D Courtney, M Grove, D Cortez, G W Reuther, A M Pendergast.   

Abstract

Oncogenic forms of the Abl and Src tyrosine kinases trigger the destruction of the Abi proteins, a family of Abl-interacting proteins that antagonize the oncogenic potential of Abl after overexpression in fibroblasts. The destruction of the Abi proteins requires tyrosine kinase activity and is dependent on the ubiquitin-proteasome pathway. We show that degradation of the Abi proteins occurs through a Ras-independent pathway. Significantly, expression of the Abi proteins is lost in cell lines and bone marrow cells isolated from patients with aggressive Bcr-Abl-positive leukemias. These findings suggest that loss of Abi proteins may be a component in the progression of Bcr-Abl-positive leukemias and identify a novel pathway linking activated nonreceptor protein tyrosine kinases to the destruction of specific target proteins through the ubiquitin-proteasome pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585502      PMCID: PMC316832          DOI: 10.1101/gad.12.10.1415

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  57 in total

1.  Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation.

Authors:  R J Deshaies
Journal:  Trends Cell Biol       Date:  1995-11       Impact factor: 20.808

2.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Authors:  M Loda; B Cukor; S W Tam; P Lavin; M Fiorentino; G F Draetta; J M Jessup; M Pagano
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

Review 3.  The viral and cellular forms of the Abelson (abl) oncogene.

Authors:  N Rosenberg; O N Witte
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

4.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

5.  Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway.

Authors:  T K Kim; T Maniatis
Journal:  Science       Date:  1996-09-20       Impact factor: 47.728

Review 6.  The function of BCR/ABL and related proto-oncogenes.

Authors:  A Gotoh; H E Broxmeyer
Journal:  Curr Opin Hematol       Date:  1997-01       Impact factor: 3.284

7.  Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.

Authors:  M L Gishizky; D Cortez; A M Pendergast
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

Authors:  T Skorski; P Kanakaraj; M Nieborowska-Skorska; M Z Ratajczak; S C Wen; G Zon; A M Gewirtz; B Perussia; B Calabretta
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

9.  Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

Authors:  I Sánchez-García; G Grütz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.

Authors:  L Puil; J Liu; G Gish; G Mbamalu; D Bowtell; P G Pelicci; R Arlinghaus; T Pawson
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  31 in total

1.  Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.

Authors:  Philippe Soubeyran; Ana Barac; Iwona Szymkiewicz; Ivan Dikic
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 2.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

3.  Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase.

Authors:  Fabio P S Santos; Hagop Kantarjian; David McConkey; Susan O'Brien; Stefan Faderl; Gautam Borthakur; Alessandra Ferrajoli; John Wright; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-08

4.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

5.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

6.  CDK1-mediated phosphorylation of Abi1 attenuates Bcr-Abl-induced F-actin assembly and tyrosine phosphorylation of WAVE complex during mitosis.

Authors:  Chunmei Zhuang; Hongxing Tang; Sharmila Dissanaike; Everardo Cobos; Yunxia Tao; Zonghan Dai
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

7.  hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.

Authors:  Angela Iervolino; Giorgia Santilli; Rossana Trotta; Clara Guerzoni; Vincenzo Cesi; Anna Bergamaschi; Carlo Gambacorti-Passerini; Bruno Calabretta; Danilo Perrotti
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.

Authors:  R Plattner; L Kadlec; K A DeMali; A Kazlauskas; A M Pendergast
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

9.  Reelin-induced tyrosine [corrected] phosphorylation of disabled 1 during neuronal positioning.

Authors:  B W Howell; T M Herrick; J A Cooper
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

Review 10.  Phosphoregulation of the WAVE regulatory complex and signal integration.

Authors:  Michelle C Mendoza
Journal:  Semin Cell Dev Biol       Date:  2013-01-24       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.